Literature DB >> 4148919

Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.

W Dairman.   

Abstract

The concentrations of tyrosine in rat plasma and brain were increased 2-7 fold by the administration of either L-tyrosine or cycloheximide. Under these conditions catecholamine concentrations in the brain and the heart remained unchanged even when the rats were maintained in a cold environment to increase catecholamine turnover. The data are interpreted to mean that an increase in the tyrosine concentration in the tissues does not result in an in vivo substrate inhibition of tyrosine hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4148919      PMCID: PMC1666031          DOI: 10.1111/j.1476-5381.1972.tb07268.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  The differential determination of catecholamines in urine.

Authors:  B D DRUJAN; T L SOURKES; D S LAYNE; G F MURPHY
Journal:  Can J Biochem Physiol       Date:  1959-10

2.  The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents.

Authors:  A Alousi; N Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

3.  Trans-synaptic induction of adrenal tyrosine hydroxylase.

Authors:  H Thoenen; R A Mueller; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-10       Impact factor: 4.030

4.  Factors influencing the rate of norepinephrine biosynthesis in nerve tissue.

Authors:  R H Roth; L Stjärne; U S von Euler
Journal:  J Pharmacol Exp Ther       Date:  1967-12       Impact factor: 4.030

5.  Mechanism of secretion from the adrenal medulla. IV. The fate of the storage vesicles following insulin and reserpine administration.

Authors:  O H Viveros; L Arqueros; R J Connett; N Kirshner
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

6.  Increased synthesis of catecholamines in the intact rat following administration of alpha-adrenergic blocking agents.

Authors:  W Dairman; R Gordon; S Spector; A Sjoerdsma; S Udenfriend
Journal:  Mol Pharmacol       Date:  1968-09       Impact factor: 4.436

7.  Increase in tyrosine hydroxylase activity after reserpine administration.

Authors:  R A Mueller; H Thoenen; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

8.  Acceleration of noradrenaline turnover in the mouse heart by cold exposure.

Authors:  A Oliverio; L Stjärne
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037

9.  Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation.

Authors:  G C Sedvall; I J Kopin
Journal:  Life Sci       Date:  1967-01-01       Impact factor: 5.037

10.  End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis.

Authors:  S Spector; R Gordon; A Sjoerdsma; S Udenfriend
Journal:  Mol Pharmacol       Date:  1967-11       Impact factor: 4.436

View more
  4 in total

1.  d-Tyrosine prevents hypertension in DOCA-saline treated uninephrectomised rats.

Authors:  B Shalita; S Dikstein
Journal:  Pflugers Arch       Date:  1979-04-30       Impact factor: 3.657

2.  Dopamine synthesis by non-dopaminergic neurons in the arcuate nucleus of rat fetuses.

Authors:  V I Mel'nikova; A V Lavrent'eva; V S Kudrin; K S Raevskii; M V Ugryumov
Journal:  Neurosci Behav Physiol       Date:  2005-10

3.  Cycloheximide and acetoxycycloheximide: inhibition of tyrosine hydroxylase activity and amnestic effects.

Authors:  L B Flexner; R G Serota; R H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

4.  Studies on memory: inhibitors of protein synthesis also inhibit catecholamine synthesis.

Authors:  L B Flexner; R H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.